Drug Information Association Logo
« Back to Listing

Orphan Drugs and Treatment of Rare Diseases in Asia

Rare/Orphan Diseases

Day & Time:
June 17, 3:30PM - 5:00PM (Pacific Standard Time)

Session Number:

Room Number:



Orphan Drugs and Treatment of Rare Diseases in Asia

Noriaki Murao, MS
NM Consulting, Japan

This symposium will focus on activities related to orphan drugs and rare diseases in Asia, examining some of the efforts from academic societies, patient organizations, and pharmaceutical companies in facilitating the diagnosis and treatment for rare diseases in Asia, along with an overview of recent regulatory measures in Japan. The symposium also includes the information on epidemiology of rare diseases in Asia.

Learning Objective(s):
Discuss the current epidemiology and developments of rare diseases in Asia including how these achievements affect other countries; Describe the orphan drug legislation and status of orphan drug development in Japan.

Presentation(s) & Speaker(s):
Government Challenges and Initiatives on Rare Diseases in Asia
Hiroshi Mizushima
Chief Senior Researcher, Center for Public Health Informatics
National Institute of Public Health, Japan

Developing Treatments of Rare Diseases in Asia
Wuh-Liang Hwu, MD, PhD
Professor in Pediatrics
National Taiwan University, Taiwan

Japanese Regulation on Orphan Medicines and Drug Development in Rare Diseases
Harumasa Nakamura, MD
Deputy Review Director, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan